OmniAb 将来の成長

Future 基準チェック /26

OmniAbは、23.5%と29.1%でそれぞれ年率23.5%で利益と収益が成長すると予測される一方、EPSはgrowで27.2%年率。

主要情報

23.5%

収益成長率

27.2%

EPS成長率

Life Sciences 収益成長	18.8%
収益成長率	29.1%
将来の株主資本利益率	n/a
アナリストカバレッジ	Good
最終更新日	13 Nov 2024

今後の成長に関する最新情報

The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 12

Recent updates

Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth?

Sep 14

Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 43%?

Jul 15

The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 12

Things Look Grim For OmniAb, Inc. (NASDAQ:OABI) After Today's Downgrade

Mar 26

Revenues Not Telling The Story For OmniAb, Inc. (NASDAQ:OABI)

Feb 28

OmniAb, Inc.'s (NASDAQ:OABI) Intrinsic Value Is Potentially 37% Above Its Share Price

Jan 15

Unpleasant Surprises Could Be In Store For OmniAb, Inc.'s (NASDAQ:OABI) Shares

Nov 11

Earnings Update: OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Are Trimming Their Forecasts

Aug 13

OmniAb, Inc. (NASDAQ:OABI) Analysts Just Cut Their EPS Forecasts Substantially

May 14

業績と収益の成長予測

NasdaqGM:OABI - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	62	-36	4	N/A	6
12/31/2025	47	-49	-41	N/A	7
12/31/2024	26	-62	-46	N/A	7
9/30/2024	20	-63	-47	-45	N/A
6/30/2024	22	-62	-47	-45	N/A
3/31/2024	21	-63	-45	-42	N/A
12/31/2023	34	-51	1	2	N/A
9/30/2023	65	-30	-2	4	N/A
6/30/2023	66	-27	-4	6	N/A
3/31/2023	66	-22	-1	12	N/A
12/31/2022	59	-22	-21	-4	N/A
9/30/2022	39	-32	-15	-1	N/A
6/30/2022	38	-28	-12	-1	N/A
3/31/2022	38	-25	-3	4	N/A
12/31/2021	35	-27	-10	-6	N/A
9/30/2021	33	-24	-2	0	N/A
12/31/2020	23	-18	4	4	N/A
12/31/2019	18	-14	-5	-5	N/A

アナリストによる今後の成長予測

収入対貯蓄率: OABI今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: OABI今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: OABI今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: OABIの収益 ( 29.1% ) US市場 ( 8.9% ) よりも速いペースで成長すると予測されています。

高い収益成長: OABIの収益 ( 29.1% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: OABIの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

OmniAb 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Consensus revenue estimates fall by 31%

No longer forecast to breakeven

Forecast to breakeven in 2026

Consensus revenue estimates fall by 22%

Consensus revenue estimates fall by 14%

Recent updates

OmniAb, Inc. to Report Q3, 2024 Results on Nov 12, 2024

Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth?

OmniAb, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Are Investors Undervaluing OmniAb, Inc. (NASDAQ:OABI) By 43%?

The OmniAb, Inc. (NASDAQ:OABI) First-Quarter Results Are Out And Analysts Have Published New Forecasts

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

OmniAb, Inc., Annual General Meeting, Jun 18, 2024

OmniAb, Inc. to Report Q1, 2024 Results on May 09, 2024

Now 21% undervalued after recent price drop

President exercised options and sold US$98k worth of stock

President exercised options to buy US$1.3m worth of stock.

President recently bought US$1.2m worth of stock

Things Look Grim For OmniAb, Inc. (NASDAQ:OABI) After Today's Downgrade

Consensus revenue estimates fall by 31%

No longer forecast to breakeven

Revenues Not Telling The Story For OmniAb, Inc. (NASDAQ:OABI)

OmniAb, Inc. to Report Q4, 2023 Results on Mar 20, 2024

President exercised options and sold US$105k worth of stock

OmniAb, Inc.'s (NASDAQ:OABI) Intrinsic Value Is Potentially 37% Above Its Share Price

Forecast to breakeven in 2026

OmniAb, Inc. Presents New Scientific Data on its OmnidAb Platform at the 2023 Antibody Engineering & Therapeutics Conference

President recently bought US$1.0m worth of stock

Executive VP of Finance & CFO exercised options and sold US$78k worth of stock

Consensus revenue estimates fall by 22%

President recently bought US$406k worth of stock

Unpleasant Surprises Could Be In Store For OmniAb, Inc.'s (NASDAQ:OABI) Shares

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Omniab, Inc. Appoints Steve Love to Its Board of Directors and as Audit Committee Chair, Member of the Human Capital Management and Compensation Committee

OmniAb, Inc. Appoints Steve Love to its Board of Directors and as Audit Committee Chair

OmniAb, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Now 20% undervalued

President recently bought US$247k worth of stock

Consensus revenue estimates fall by 14%

Earnings Update: OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Are Trimming Their Forecasts

Now 22% undervalued

Omniab Announces the Passing of Director Sunil Patel

OmniAb, Inc. to Report Q2, 2023 Results on Aug 10, 2023

President recently bought US$520k worth of stock

Chairman notifies of intention to sell stock

Consensus revenue estimates fall by 10%

President recently bought US$1.5m worth of stock

OmniAb, Inc. (NASDAQ:OABI) Analysts Just Cut Their EPS Forecasts Substantially

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Full year 2022 earnings: EPS and revenues exceed analyst expectations

President recently bought US$565k worth of stock

Independent Director recently bought US$84k worth of stock

President recently bought US$1.0m worth of stock

No independent directors

President recently bought US$276k worth of stock

Chairman exercised options to buy US$533k worth of stock.

OmniAb, Inc. completed the acquisition of Avista Public Acquisition Corp. II (NasdaqCM:AHPA) (APAC) from Avista Capital Holdings, L.P., Polar Asset Management Partners Inc., Citadel Advisors LLC, HGC Investment Management Inc., Beryl Capital Management LLC and others.

OmniAb, Inc. Appoint Board of Directors

No independent directors

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘